Parallax Volatility Advisers’s Roivant Sciences ROIV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-73,700
Closed -$872K 2048
2024
Q4
$872K Buy
+73,700
New +$871K ﹤0.01% 1365
2024
Q1
Sell
-686,200
Closed -$7.71M 2267
2023
Q4
$7.71M Buy
686,200
+618,800
+918% +$6.03M 0.02% 671
2023
Q3
$787K Buy
+67,400
New +$762K ﹤0.01% 1456

Other funds holding ROIV

Parallax Volatility Advisers's ROIV Position: Q1 2025 in Review

Parallax Volatility Advisers sold out of Roivant Sciences (ROIV) in Q1 2025, closing a stake of 21,878 shares — an estimated $259K sold.

Parallax Volatility Advisers first reported a position in ROIV in Q3 2024 and held it in 2 quarters. The position peaked at $347K in Q3 2024. 312 funds tracked by Wall St. Rank hold ROIV as of Q1 2025.

  • Parallax Volatility Advisers reported no remaining Roivant Sciences position as of Q1 2025 after selling out during the quarter.
  • Parallax Volatility Advisers sold 21,878 Roivant Sciences shares in Q1 2025, an estimated $259K.
  • Parallax Volatility Advisers first reported a position in Roivant Sciences in Q3 2024 and held it in 2 quarters.
  • Parallax Volatility Advisers's Roivant Sciences position peaked at $347K in Q3 2024.
  • 312 funds tracked by Wall St. Rank held Roivant Sciences as of Q1 2025.

Based on Parallax Volatility Advisers's 13F filing for Q1 2025, filed 15 May 2025.